A human ESC line for efficient CRISPR editing of pluripotent stem cells

被引：2
|
作者：
Sintov, Elad [1 ]
Gerace, Dario [1 ]
Melton, Douglas A. [1 ,2 ]
机构：
[1] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
来源：
STEM CELL RESEARCH | 2021年 / 57卷
关键词：
D O I：
10.1016/j.scr.2021.102591
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Human pluripotent stem cells (hPSC) can be directed to differentiate in vitro into insulin-prorducing beta cells (SC-beta). Although these cells accurately respond to glucose and can reverse diabetes in preclinical models improvments in the final cell products are desirable. For example, safety, controlling the cellular compositions and protection against immune rejection may be addressed by genetic modifications of SC-beta pre-transplantation. To screen for gene targets, we have generated a human embryonic stem cell line (hESC) that constitutively express the enhanced specificity Streptococcus pyogenes Cas9 (eSpCas9) gene, knocked-in into the GAPDH locus.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells
    Loh, Kyle M.
    Palaria, Amrita
    Ang, Lay Teng
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (148):
  • [42] Gene delivery methods and genome editing of human pluripotent stem cells
    Czerwinska, Patrycja
    Mazurek, Sylwia
    Kolodziejczak, Iga
    Wiznerowicz, Maciej
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2019, 24 (02) : 180 - 187
  • [43] CNS disease models with human pluripotent stem cells in the CRISPR age
    Muffat, Julien
    Li, Yun
    Jaenisch, Rudolf
    CURRENT OPINION IN CELL BIOLOGY, 2016, 43 : 96 - 103
  • [44] Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions
    Hendriks, William T.
    Warren, Curtis R.
    Cowan, Chad A.
    CELL STEM CELL, 2016, 18 (01) : 53 - 65
  • [45] The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
    Zhu, Zengrong
    Gonzalez, Federico
    Huangfu, Danwei
    USE OF CRISPR/CAS9, ZFNS, AND TALENS IN GENERATING SITE-SPECIFIC GENOME ALTERATIONS, 2014, 546 : 215 - 250
  • [46] Optimizing Nonviral CRISPR Epigenome Editing in Human Mesenchymal Stem Cells
    Hamann, Andrew
    Broad, Kelly
    Pannier, Angela K.
    MOLECULAR THERAPY, 2022, 30 (04) : 101 - 101
  • [47] Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
    Claudia De Masi
    Paola Spitalieri
    Michela Murdocca
    Giuseppe Novelli
    Federica Sangiuolo
    Human Genomics, 14
  • [48] An Ultrasensitive Calcium Reporter System via CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells
    Jiang, Yuqian
    Zhou, Yuxiao
    Bao, Xiaoping
    Chen, Chuanxin
    Randolph, Lauren N.
    Du, Jing
    Lian, Xiaojun Lance
    ISCIENCE, 2018, 9 : 27 - +
  • [49] Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
    De Masi, Claudia
    Spitalieri, Paola
    Murdocca, Michela
    Novelli, Giuseppe
    Sangiuolo, Federica
    HUMAN GENOMICS, 2020, 14 (01)
  • [50] Genome editing in induced pluripotent stem cells
    Cheng, Li-Tao
    Sun, Liang-Tso
    Tada, Takashi
    GENES TO CELLS, 2012, 17 (06) : 431 - 438
12345